Showing results (1161-1170 of 3,473) with videos related to

Sort By:
Pageof 348
Clinical Pharmacokinetics|September 18, 2016
Impact of Demographics, Organ Impairment, Disease, Formulation, and Food on the Pharmacokinetics of the Selective S1P1 Receptor Modulator Ponesimod Based on 13 Clinical StudiesDominik Lott, Thorsten Lehr, Jasper Dingemanse, et al.
Clinical Pharmacokinetics|September 3, 2016
A Nonparametric Method to Optimize Initial Drug Dosing and Attainment of a Target Exposure Interval: Concepts and Application to Busulfan in PediatricsMichaël Philippe, Michael Neely, Yves Bertrand, et al.
Clinical Pharmacokinetics|May 17, 2017
Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-GlucuronideSjoerd de Hoogd, Pyry A J Välitalo, Albert Dahan, et al.
Clinical Pharmacokinetics|May 20, 2017
A Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of VedolizumabMaria Rosario, Nathanael L Dirks, Catherine Milch, et al.
Clinical Pharmacokinetics|June 23, 2017
Intracellular Pharmacokinetics of Antibacterials and Their Clinical ImplicationsFederico Pea
Clinical Pharmacokinetics|May 1, 1985
Effects of ethanol on drug and metabolite pharmacokineticsE A Lane, S Guthrie, M Linnoila
Clinical Pharmacokinetics|September 26, 2016
Evaluation of Concomitant Antiretrovirals and CYP2C9/CYP2C19 Polymorphisms on the Pharmacokinetics of EtravirineBruce Green, Herta Crauwels, Thomas N Kakuda, et al.
Clinical Pharmacokinetics|April 7, 2018
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal ImpairmentCharlotte Granhall, Flemming L Søndergaard, Mette Thomsen, et al.
Clinical Pharmacokinetics|April 7, 2018
Infliximab Pharmacokinetics are Influenced by Intravenous Immunoglobulin Administration in Patients with Kawasaki DiseaseNiels Vande Casteele, Jun Oyamada, Chisato Shimizu, et al.
Clinical Pharmacokinetics|April 18, 2018
Clinical Investigation of Coproporphyrins as Sensitive Biomarkers to Predict Mild to Strong OATP1B-Mediated Drug-Drug InteractionsAnnett Kunze, Emmanuel Njumbe Ediage, Lieve Dillen, et al.
Pageof 348